HR Execs on the Move

Impedimed

www.impedimed.com

 
ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMed`s primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.impedimed.com
  • 5900 Pasteur Ct Suite 125
    Carlsbad, CA USA 92008
  • Phone: 760.585.2100

Executives

Name Title Contact Details
Eric Mueller
 Director of Financial Planning and Analysis Profile
Dennis Schlaht
 SVP R&D and Technology Profile
Shashi Tripathi
 Chief Technology and Chief Customer Officer Profile

Similar Companies

www.biosig.com

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.

CardiacAssist, Inc.

CardiacAssist, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Tarheel Physicians Supply

Tarheel Physicians Supply is a Wilmington, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viveve

Viveve provides women low risk, high reward medical procedures that promote personal health and wellness.

Pelton Shepherd Industries

Pelton Shepherd Industries is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.